Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 3/20 | 0.41 |
| ▸ | MAT2A | P31153 | 2/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | TACR1 | P25103 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.32 |
| ▸ | F7 | P08709 | 1/20 | 0.32 |
| ▸ | F3 | P13726 | 1/20 | 0.32 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | CCR1 | P32246 | 1/20 | 0.31 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.30 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.30 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22158530 | 0.95 | MAT2A (0.36) | KIF11MAT2AGLAMAPTF7 | |
| SCHEMBL22157688 | 0.93 | KIF11 (0.38) | KIF11MAT2AGLATACR1MAPT | |
| SCHEMBL23299850 | 0.89 | KIF11 (0.42) | KIF11MAT2ATACR1MAPTHSP90AA1 | |
| SCHEMBL22158535 | 0.87 | KIF11 (0.36) | KIF11MAT2AMAPTF7F3 | |
| SCHEMBL22158531 | 0.87 | KIF11 (0.46) | KIF11MAT2AGLAHSP90AA1F7 | |
| SCHEMBL22156763 | 0.86 | KIF11 (0.39) | KIF11MAT2AHSP90AA1F7F3 | |
| SCHEMBL22156756 | 0.86 | KIF11 (0.39) | KIF11MAT2AHSP90AA1F7F3 | |
| SCHEMBL22157675 | 0.84 | KIF11 (0.40) | KIF11TACR1MAPTHSP90AA1LMNA | |
| SCHEMBL22158641 | 0.84 | KIF11 (0.37) | KIF11TACR1 | |
| SCHEMBL22158534 | 0.83 | KIF11 (0.41) | KIF11MAT2AHSP90AA1F7F3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3635070-B1 | ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2021-04-28 | — | — | EP | disclosed |
| US-20200203628-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200203628-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, ORC3, OR51E2 | KIF11 4485/4885MAT2A 3952/4885GLA 4219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.